MSB vs PGC

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

38LOW

PGC

PARAGON FPO [PGC]

38LOW

Score Breakdown

MSB PGC
Technical
55
71
Catalyst
54
50
Sentiment
50
50
Fundamental
66
87
Momentum
67
28
Risk Gate
40
50

Key Metrics

MSB Metric PGC
$2.7BMarket Cap$314.5M
4.4MAvg Volume (20d)438K
+8.3%Short Interest+0.1%
$3.31052-Week High$0.450
$1.51552-Week Low$0.170
+6.3%Daily Change+10.5%
$2.190Entry Price$0.210
-18.2%ROE-4.5%
-144.3%Profit Margin-0.4%

Active Signals

MSB Signals

●MACD momentum is picking up steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Strong revenue growth (+1527%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

PGC Signals

●MACD momentum is picking up steam
●Pressing against the upper Bollinger Band — extended and may need to cool off
●Volume surging at 2.5x normal while price climbs — real buying conviction behind this move
●Just broke above 20-day resistance — a level that was capping price, now cleared
●On a tear — up 20.0% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.1x)

Ask Scout AI to compare MSB and PGC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MSB Full Analysis → PGC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).